CAS NO: 191732-72-6
Batch Molecular FormulaC13H13N3O3
Batch Molecular Weight259.261
StorageStore at RT
Batch Molecular Structure

Lenalidomide is a medication that belongs to a class of drugs known as immunomodulatory agents. It is used to treat various medical conditions, with its primary use being in the treatment of certain cancers and blood disorders. Here are some key points about lenalidomide:

  1. Indications: Lenalidomide is used to treat several medical conditions, including:
    • Multiple Myeloma: Lenalidomide is often used in combination with other medications to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.
    • Myelodysplastic Syndromes (MDS): Lenalidomide is also used in the treatment of certain types of myelodysplastic syndromes, which are a group of blood disorders characterized by abnormal blood cell production.
    • Mantle Cell Lymphoma: In some cases, lenalidomide may be prescribed for the treatment of mantle cell lymphoma, a type of non-Hodgkin lymphoma.
  2. Mechanism of Action: Lenalidomide’s exact mechanism of action is not fully understood, but it is thought to have several effects on the immune system and the bone marrow environment. It can enhance the immune system’s ability to target and destroy cancer cells and inhibit the growth of abnormal cells in the bone marrow.
  3. Administration: Lenalidomide is typically taken orally in the form of capsules. The dosage and treatment schedule will vary depending on the specific condition being treated and may be used alone or in combination with other medications.
  4. Side Effects: Lenalidomide can have potential side effects, which may include fatigue, dizziness, nausea, diarrhea, and an increased risk of infections. It can also have more serious side effects, such as a risk of blood clots, birth defects if taken during pregnancy, and a risk of secondary primary malignancies. Close monitoring by a healthcare provider is essential to manage and minimize potential side effects.
  5. Contraindications: Lenalidomide is generally not prescribed for pregnant women due to its teratogenic effects (ability to cause birth defects). It is also not recommended for individuals with a known hypersensitivity to lenalidomide.
  6. Pregnancy and Lactation: Lenalidomide is known to cause birth defects and should not be used during pregnancy. It is also not recommended during breastfeeding.

Lenalidomide is a potent medication with the potential for significant side effects, and it should only be used under the close supervision and guidance of a healthcare provider who is experienced in its use. If you are prescribed lenalidomide, it’s important to follow your healthcare provider’s recommendations, attend regular check-ups, and communicate any concerns or side effects you may experience during your treatment.


  • Lenalidomide is used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS).